Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Matthew Herper On The New Genetic Revolution
Forbes
Thursday, December 17, 2009 - 9:22am
tags:
genetics, genetic medicine
Talecris Bounces Off IPO Price: Strong Growth Potential
Seeking Alpha
Thursday, December 17, 2009 - 9:21am
tags:
IPOs, Talecris
A Certificate Program For Pharma Sales Reps Is On Its Way
Pharmalot
Thursday, December 17, 2009 - 9:18am
tags:
drug reps, Medical Representatives Certification Commission
Siga Technologies: Is the Volatility Over?
Seeking Alpha
Thursday, December 17, 2009 - 9:17am
tags:
SIGA technologies
Ipsen, Roche’s Taspoglutide Matches Sanofi’s Lantus
Bloomberg
Thursday, December 17, 2009 - 8:57am
tags:
Lantus, diabetes, Ipsen, Roche, taspoglutide
Panel Rejects Early Use of Tarceva
WSJ Online
Wednesday, December 16, 2009 - 10:10pm
tags:
Tarceva, OSI Pharmaceuticals, FDA, lung cancer, Roche, Genentech
Efficacy of Roche's Flu Drug Tamiflu In Doubt
BNET Pharma
Wednesday, December 16, 2009 - 5:51pm
tags:
Roche, Flu, Tamiflu
Better Buy: Johnson & Johnson or Bristol-Myers Squibb?
Motley Fool
Wednesday, December 16, 2009 - 5:50pm
tags:
JNJ, Bristol-Myers Squibb
Amylin Impresses in Head-to-Head
Yahoo/Zacks.com
Wednesday, December 16, 2009 - 5:48pm
tags:
Johnson & Johnson's Ethicon unit paying $785 million for sinus surgery device maker Acclarent
Yahoo/AP
Wednesday, December 16, 2009 - 5:48pm
tags:
JNJ, M&A, Acclarent, medical devices
Gilead's Phase 3 Train Wreck
Motley Fool
Wednesday, December 16, 2009 - 3:34pm
tags:
Gilead Sciences, darusentan
Drug stocks rise; Achillion, Sanofi in play
Marketwatch
Wednesday, December 16, 2009 - 11:34am
tags:
drug stocks, Achillion, Sanofi
Biotech CEO salaries up, but bonuses down
Fierce Biotech
Wednesday, December 16, 2009 - 11:33am
tags:
biotech, salaries
Achillion shares rocket up on promising hep C data
Fierce Biotech
Wednesday, December 16, 2009 - 11:32am
tags:
Achillion, hepatitis C
PhRMA's $80B deal helps nix reimportation
Fierce Pharma
Wednesday, December 16, 2009 - 11:30am
tags:
PhRMA, reimportation, healthcare reform
Micromet: Opportunity Lies in Breakthrough BiTE Antibody
Seeking Alpha
Wednesday, December 16, 2009 - 11:25am
tags:
antibodies, Micromet
Five Biotech Events to Watch in 2010
TheStreet.com
Wednesday, December 16, 2009 - 11:20am
tags:
biotech, Medivation, Elan, Pfizer, Dendreon, Vertex Pharmaceuticals, Amgen, InterMune
Cell Therapeutics Gets FDA Panel for Lymphoma Drug
TheStreet.com
Wednesday, December 16, 2009 - 10:42am
tags:
FDA, Cell Therapeutics, lymphoma, pixantrone
Bristol-Myers sets rate for Mead stock swap
Marketwatch
Wednesday, December 16, 2009 - 10:41am
tags:
Mead Johnson, Bristol-Myers Squibb
4-Star Stocks Poised to Pop: Eli Lilly
Motley Fool
Wednesday, December 16, 2009 - 10:40am
tags:
Eli Lilly

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.